Novartis Everolimus Transition

Graft Dysfunction Clinical Trial

Official title:
Safety and Efficacy of Everolimus Transition in Minimizing Progressive Graft Dysfunction and Interstitial Fibrosis in Adult Kidney Transplant Recipients

Status Completed

Clinical Trial Summary

Transition from tacrolimus based triple therapy with Mycophenolate Mofetil (MMF) and steroids in stable renal transplant patients to low intensity tacrolimus, everolimus and prednisone will be associated with improvement in Glomular Filtration Rate (GFR) and allograft fibrosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02096107
Study type	Interventional
Source	Medical University of South Carolina
Contact
Status	Completed
Phase	Phase 4
Start date	February 2014
Completion date	May 2017

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01564095` - TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion	Phase 2/Phase 3
Recruiting	`NCT05031052` - Normothermic Machine Perfusion (NMP) Versus Static Cold Storage (SCS) in Human Kidney Transplantation	N/A
Completed	`NCT04420897` - The Effect of Intraoperative Arterial Oxygen Pressures on Early Post-Operative Patient and Graft Survival in Living Donor Kidney Transplantation
Recruiting	`NCT02826811` - Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK	N/A
Recruiting	`NCT03808324` - Heart Failure After Heart Transplantation Due to Chronic Rejection	N/A
Recruiting	`NCT03786991` - EPI-STORM: Cytokine Storm in Organ Donors